Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Gree a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2065
https://www.valueinhealthjournal.com/article/S1098-3015(14)03995-3/fulltext
Title :
Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Gree a Cost Effectiveness Analysis Based on Clinical Trial and Real-World Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03995-3&doi=10.1016/j.jval.2014.08.2065
First page :
A597
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1530